An Asthma Mobile Intervention to Promote Patient-Reported Outcomes in Primary Care

Clinical Trial ID: NCT03847142


Through this study, the investigators will adapt the ASTHMAXcel mobile app and evaluate the adapted intervention through a randomized controlled trial.

Through this study, the investigators will use patient and provider feedback to adapt the ASTHMAXcel mobile intervention, and will conduct a randomized controlled trial to test the intervention's impact on clinical and process outcomes.


Inclusion Criteria: English-speaking individuals >18 years with: 1. persistent asthma(diagnosis made by a healthcare provider) on a daily controller medication 2. able to give informed consent 3. Smartphone (iOS or Android) access Exclusion Criteria: 1. use of oral corticosteroids in the 2 weeks prior to the baseline visit 2. pregnancy 3. severe psychiatric or cognitive problems that would prohibit an individual from completing the protocol 4. patients that previously received ASTHMAXcel

  • Start Date


  • Last Updated


  • Sponsor

    Montefiore Medical Center

  • Condition Name


Learn about this trial.

Check the eligibility requirements, study details, and more.

Related Trials

Different trials target different symptoms, condition types, and patients. Learn more about other emergeing treatments being investigated now.